ACTRN12606000273583已完成3 期
Randomised controlled trial of intravenous immunoglobulin of neonates with sepsis using intravenous immunoglobulin (Intragam P) and being treated with antibiotics. Primary outcomes are mortality and morbidity.
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 5,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- Days 至 28 Days（—）
- 性别
- All
入选标准
- •Infants are eligible if: they are receiving antibiotics with clinical evidence of definite or highly probable sepsis, there is substantial uncertainty that IVIG is indicated, birth weight is less than 1500g OR already has positive blood or cerebro spinal fluid culture OR receiving artifical ventilation.
排除标准
- •IVIG already given or thought to be needed or contra-indicated.
研究者
相似试验
终止
4 期
A Randomised Controlled trial of intravenous immunoglobulin (IVIg) compared with pulse methyl-prednisolone for the treatment of chronic active antibody mediated rejectioACTRN12612000252819Dr William Mulley30
尚未招募
3 期
Trial for Use of a drug called Intravenous Immunoglobulin in young patients with dilated heart conditioCTRI/2018/01/011421All india institute of medical sciences New Delhi
已完成
3 期
a clinical trial to find the most appropriate maintenance fluid in children with central nervous system infectioCTRI/2012/05/002637Kalawati Saran Chiuldrens Hospital90
已完成
不适用
Randomised placebo-controlled trial of intravenous methylprednisolone in relapsed multiple sclerosis patients without the need for ranitidine coverMultiple sclerosiservous System Diseases: Multiple sclerosis (MS)Nervous System DiseasesISRCTN46231139Department of Health (UK)60
已完成
3 期
A prospective randomized controlled trial of immunoglobulin plus prednisolone for Kawasaki disease patients with high risk for coronary abnormalitiesKawasaki diseaseJPRN-UMIN000009524agoya University Graduate School of Medicine, Department of Pediatrics240